Somatostatin analogs for pancreatic neuroendocrine tumors: is there any benefit when Ki-67 Is >= 10%?
Merola, E Gordoa, TA Zhang, P Al-Toubah, T Pelle, E Liu, M Laskaratos, F de Mestier, L Lamarca, Angela Hernando, J
Merola, E
Gordoa, TA
Zhang, P
Al-Toubah, T
Pelle, E
Liu, M
Laskaratos, F
de Mestier, L
Lamarca, Angela
Hernando, J
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Merola E, Gordoa T, Zhang P, Al-Toubah T, Pelle E, Liu M, et al. Somatostatin analogs for pancreatic neuroendocrine tumors: is there any benefit when Ki-67 Is >= 10%? Neuroendocrinology. 2020;110:197-